BioForce Nanosciences Holdings, Inc. Share Price Other OTC
Equities
BFNH
US09064C2061
Other Specialty Retailers
Sales 2022 | - | Sales 2023 | - | Capitalization | 58.84M 4.71B |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net Debt 2022 | 173K 13.87M | Net Debt 2023 | 220K 17.61M | EV / Sales 2023 | - |
P/E ratio 2022 |
-120
x | P/E ratio 2023 |
-101
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 14.4% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Gagnon
CEO | Chief Executive Officer | 62 | 29/11/21 |
John LaViolette
CEO | Chief Executive Officer | 62 | 29/11/21 |
Sasha Shapiro
PSD | President | 61 | 29/11/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Merle Ferguson
CHM | Chairman | 76 | 07/07/13 |
Richard Kaiser
DFI | Director of Finance/CFO | 59 | 30/06/13 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 843M | |
-1.57% | 652M | |
+2.25% | 378M | |
+23.66% | 227M | |
0.00% | 145M | |
+110.87% | 59.85M |